TIME BioVentures logo

TIME BioVentures

North America, California, United States, Los Angeles

Description

Time BioVentures is an early-stage life sciences and healthcare venture capital firm.

Investor Profile

TIME BioVentures has made 8 investments, with 2 in the past 12 months and 13% as lead.

Stage Focus

  • Series A (50%)
  • Series C (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Diagnostics
  • Health Care
  • Medical
  • Therapeutics
  • Hospital
  • Medical Device
  • Biopharma
  • Mental Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does TIME BioVentures frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
Libertus Capital
Europe, England, United Kingdom, London
Co-Investments: 2
ACME Capital
North America, Florida, United States, Boca Raton
Co-Investments: 2
Norwest Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 2
CH
North America, California, United States, Ross
Co-Investments: 2
Hummingbird Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Watermael-boitsfort
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 2
Fifty Years
North America, California, United States, San Francisco
Co-Investments: 2
Neotribe Ventures
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does TIME BioVentures often collaborate with?

AW
North America, California, United States, San Francisco
Shared Deals: 1
EC
North America, Massachusetts, United States, Boston
Shared Deals: 1
MW
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 1

What are some of recent deals done by TIME BioVentures?

Conceivable Life Sciences

New York, New York, United States

Conceivable Life Sciences is an AI automation company that offers an automated IVF lab for cell therapies.

BiotechnologyLife ScienceMedical
Series AJan 14, 2025
Amount Raised: $18,000,000
Rivermark Medical

Milwaukee, Wisconsin, United States

Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.

Health CareHospitalMedical Device
Series COct 10, 2024
Amount Raised: $30,000,000
Brightside Health

San Francisco, California, United States

Brightside Health is a telemedicine platform integrating precision psychiatry with advanced therapeutic techniques.

Health CareMental HealthTelehealthTherapeuticsWellness
Series CMar 26, 2024
Amount Raised: $33,000,000
Commons Clinic

Los Angeles, California, United States

Commons Clinic is a multi-specialty clinic offering minimally-invasive surgical and conservative musculoskeletal care.

Health CareHospitalPersonal Health
Series AOct 9, 2023
Amount Raised: $19,500,000
BillionToOne

Menlo Park, California, United States

BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.

BiotechnologyGeneticsHealth DiagnosticsMedical
Series CDec 15, 2022
Amount Raised: $48,500,000
BillionToOne

Menlo Park, California, United States

BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.

BiotechnologyGeneticsHealth DiagnosticsMedical
Series CMar 30, 2022
Amount Raised: $125,000,000
NanoMosaic

Woburn, Massachusetts, United States

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

BiopharmaBiotechnologyGeneticsHealth DiagnosticsTherapeutics
Series ADec 6, 2021
Amount Raised: $40,750,000
DeepSight Technology

San Francisco, California, United States

DeepSight Technology's vision is to reinvent diagnostic imaging.

Medical Device
Series AOct 11, 2021
Amount Raised: $25,000,000